Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07331259
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of C3G (confirmed by biopsy, only if available)
* Aged ≥18 years at time of index date.
* At least 6 months of baseline period preceding index date.
* Users of iptacopan treatment including those who have discontinued iptacopan within the last twelve weeks.
Exclusion Criteria:
* Interventional C3G clinical trial participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT07331259
Study Brief:
Protocol Section:
NCT07331259